Tamoxifen Use and Impact on the Incidence of Endometrial Carcinoma: Should Tamoxifen use be discontinued?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tamoxifen Use and Impact on the Incidence of Endometrial Carcinoma: Should Tamoxifen use be discontinued?

Published:2006-03 Issue:1 Volume:37 Page:25-30
ISSN:0820-5930
Container-title:Canadian Journal of Medical Radiation Technology
language:en
Short-container-title:Canadian Journal of Medical Radiation Technology

Author:

Klassen Andrew

Publisher

Elsevier BV

Subject

General Medicine

Reference47 articles.

1. Gene expression changes induced by estrogen and selective estrogen receptor modulators in primarycultured human endometrial cells: signals that distinguish the human carcinogen tamoxifen;Pole;Toxicology,2005

2. (Risk and prognosis of endometrial cancer after tamoxifen for breast cancer;Bergman;Lancet,2000

3. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors;Bober;Journal of Clinical Oncology,2004

4. National Cancer Institute of Canada. Canadian Cancer Statistics 2004. Toronto; 2004:86-88.

5. (Tamoxifen exerts agonistic effects on clusterin and complement C3 gene expression in RUCA-I primary xenografts and metastases but not normal uterus;Zierau;Endocrine-Related Cancer,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP